Angiomax side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Angiomax. Common side effects include coronary artery thrombosis among females and coronary artery thrombosis among males.
The phase IV clinical study is created by eHealthMe based on 2,298 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2,298 people who take Angiomax and have side effects are studied.
What is Angiomax?
Angiomax has active ingredients of bivalirudin. eHealthMe is studying from 2,294 Angiomax users for its effectiveness, alternative drugs and more.
Number of Angiomax reports submitted per year:
Angiomax side effects by time on the drug *:
Angiomax side effects by gender *:
Angiomax side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Angiomax?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on bivalirudin (the active ingredients of Angiomax) and Angiomax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Angiomax:
- Angiomax (2,294 reports)
Common Angiomax side effects:
- Hypotension (abnormally low blood pressure): 181 reports
- Heart attack: 150 reports
- Chest pain: 137 reports
All Angiomax side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lexapro and Mittelschmerz - 3 seconds ago
- Ticagrelor and Cyclobenzaprine Hydrochloride drug interaction - 24 seconds ago
- Gout Aggravated in Lasix, how severe and when it was recovered? - 30 seconds ago
- Klor-Con and Osteomyelitis - 34 seconds ago
- Macrodantin and Xeljanz Xr drug interaction - 38 seconds ago
- Viagra and Stent - 57 seconds ago
- Multiple Myeloma and drugs of ingredients of levothyroxine sodium - a minute ago
- Raynaud'S Phenomenon and Hyperglycemia - a minute ago
- Lescol and Gastric Cancer - a minute ago
- Alrex and Lucentis drug interaction - a minute ago